Latest Updates
-
Kanya Pujan During Navratri 2026: Astrologer Gauri Jain On Significance, Rituals And Dussehra Traditions -
Durga Puja Pandals In Noida 2026: 7 Best Spots to Visit, From Grand Themes to Community Celebrations -
‘Breaking Bad’ Actor RJ Mitte Passes Away At 34: ‘Finite Amount Of Time’ Words From Final Interview Resurface -
Who Was Madhu Kambikar? Marathi Actress Who Took Lavani To Wider Audiences Passes Away At 73 -
International Day for Disaster Risk Reduction 2026: Why Disaster Preparedness Must Begin At Home -
Navratri Day 3: Maa Chandraghanta, Puja, Rituals, Colour, Significance, And Things To Do -
World Thrombosis Day 2026: Understanding Blood Clot Risks In Women And Their Warning Signs -
Anoushka Shankar Brings Her Global Musical Identity To Zoya’s Spice-Inspired High Jewellery Campaign -
Can A Healthy 25-Year-Old Get Lymphoma? Here Is What To Know -
Navratri 2026 Outfit Ideas To Stay Stylish And Special Throughout The Nine Days Of Festivities
Bengaluru Scientists Have Found A New Painkiller For Chronic Or Neuropathic Pain
In a new study, two scientists at the Indian Institute of Science (IISc), Bengaluru have found a new painkiller for cancer patients or people who are amputated or undergone surgery who feel persistent and severe pain for weeks or months.
The study conducted by Saurabh Yadav and Avadhesha Surolia from IISc's Molecular Biophysics Unit examined how an enzyme that usually digests bacteria can promote chronic pain related to nerve injury. The study involved mice, rats and human postmortem tissues [1] .

The result of the study will help explain how injuries and inflammation in neurons can elevate pain sensitivity. It also suggests that the inhibitors of the enzyme could be a possible therapy for chronic or neuropathic pain.
Pain is divided into two groups - inflammatory and neuropathic or chronic pain, which is stimulated by damage to the central nervous system. The former one can be controlled with normal painkillers, but excepting opioids, there is no other option for doctors to tackle the second type of pain.
Neuropathic pain is caused by a damage or disease affecting the somatosensory nervous system. The current treatment options are ineffective against such pain.
According to Avadhesha Surolia, they identified lysozyme - a bacteria eating enzyme and an important part of the immune system as the main contributor to the development of neuropathic pain.
Both the scientists found two ways to disrupt lysozyme's functions in the body, leading to two potential drug targets. They will further find out which one of these two ways is better and if there are any side effects.
Apart from improving a person's health, a new painkiller would have a huge contribution to enhance economic productivity.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
- [1] Yadav, S., & Surolia, A. (2019). Lysozyme elicits pain during nerve injury by neuronal Toll-like receptor 4 activation and has therapeutic potential in neuropathic pain.Science Translational Medicine,11(504), eaav4176.



Click it and Unblock the Notifications
